SCIENCE & TECHNOLOGY

Precision

Solutions

Contact Us

DxDirect

DxCollect

DxTerity’s genomic platform

1
CLPA Reaction

CLPA reaction converts each mRNA to a uniquely-sized ligation product at a 1:1 ratio.

2
PCR Amplification

PCR amplification—each gene is a unique size.

3
Readout

High throughput readout using ThermoFisher 3500Dx CE instrument.

CLPA-based testing platform offers direct-from-blood & tissue (including FFPE) testing of RNA

Lower cost and more scalable than qPCR/NGS for mid-plex (~60) gene expression analysis

Utilizes existing install base of ABI 3500Dx Genetic Analysers supported by Thermo-Fisher

6 hours sample to answer and up to 1500 samples per day/system

TAT 7 business days available

Analytical process

DxTerity has innovated across the analytical process. DxDirect’s unique workflow eliminates the need for sample purification, enabling high-throughput processing. This simplification is driven by the heart of the system, Non-Enzymatic Chemical Ligation.

This system uses uniquely sized, adjacently binding, chemically reactive probes (S-Probe and L-Probe) to target genes of interest. Upon binding to the RNA target, the adjacent probes spontaneously ligate and create reaction products which can be detected using industry standard instrumentation, such as PCR and capillary electrophoresis.

Explore development services

Learn how our platform can support your diagnostic program.

Contact Us

Stay in the know.

Get the latest updates and news.

DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.

Products

Development Services

Technology

News

Contact us

SCIENCE & TECHNOLOGY

Precision

Solutions

Contact Us

DxDirect

DxCollect

DxTerity’s genomic platform

1
CLPA Reaction

CLPA reaction converts each mRNA to a uniquely-sized ligation product at a 1:1 ratio.

2
PCR Amplification

PCR amplification—each gene is a unique size.

3
Readout

High throughput readout using ThermoFisher 3500Dx CE instrument.

CLPA-based testing platform offers direct-from-blood & tissue (including FFPE) testing of RNA

Lower cost and more scalable than qPCR/NGS for mid-plex (~60) gene expression analysis

Utilizes existing install base of ABI 3500Dx Genetic Analyzers supported by ThermoFisher

6 hours sample to answer and up to 1500 samples per day/system

TAT 7 business days available

Analytical process

DxTerity has innovated across the analytical process. DxDirect’s unique workflow eliminates the need for sample purification, enabling high-throughput processing. This simplification is driven by the heart of the system, Non-Enzymatic Chemical Ligation.

This system uses uniquely sized, adjacently binding, chemically reactive probes (S-Probe and L-Probe) to target genes of interest. Upon binding to the RNA target, the adjacent probes spontaneously ligate and create reaction products which can be detected using industry standard instrumentation, such as PCR and capillary electrophoresis.

Explore development services

Learn how our platform can support your diagnostic program.

Contact Us

Stay in the know.

Get the latest updates and news.

DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.